Literature DB >> 31708704

Sinoatrial Arrest Caused by Ticagrelor after Angioplasty in a 62-Year-Old Woman with Acute Coronary Syndrome.

Fan Ye, Burton V Silverstein, Michael Jansen, Christopher L Bray, Arthur C Lee.   

Abstract

The platelet aggregation inhibitor ticagrelor, a P2Y12 receptor antagonist, is widely used after angioplasty in patients with acute coronary syndrome. Clinical trial data have shown that it is well tolerated by most patients. We present the case of a 62-year-old woman whose ticagrelor-related asymptomatic and persistent sinus pauses after angioplasty resolved when ticagrelor was replaced with prasugrel.
© 2019 by the Texas Heart® Institute, Houston.

Entities:  

Keywords:  Acute coronary syndrome/drug therapy; arrhythmias, cardiac/diagnosis/physiopathology; bradycardia/chemically induced; electrocardiography/drug effects; myocardial infarction/drug therapy; platelet aggregation inhibitors/adverse effects/therapeutic use; receptors, purinergic P2Y12; ticagrelor/adverse effects; treatment outcome

Mesh：

Substances：

Year:  2019        PMID： 31708704      PMCID： PMC6827480          DOI： 10.14503/THIJ-17-6554

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


  14 in total

1.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Ezra A Amsterdam; Nanette K Wenger; Ralph G Brindis; Donald E Casey; Theodore G Ganiats; David R Holmes; Allan S Jaffe; Hani Jneid; Rosemary F Kelly; Michael C Kontos; Glenn N Levine; Philip R Liebson; Debabrata Mukherjee; Eric D Peterson; Marc S Sabatine; Richard W Smalling; Susan J Zieman
Journal:  Circulation       Date:  2014-09-23       Impact factor: 29.690

Review 2.  Bradyarrhythmias: Clinical Presentation, Diagnosis, and Management.

Authors:  Shu-Fen Wung
Journal:  Crit Care Nurs Clin North Am       Date:  2016-06-22       Impact factor: 1.326

Review 3.  Diagnosis, pathophysiology, and management of exercise-induced arrhythmias.

Authors:  Eduard Guasch; Lluís Mont
Journal:  Nat Rev Cardiol       Date:  2016-11-10       Impact factor: 32.419

4.  Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.

Authors:  Robert F Storey; Steen Husted; Robert A Harrington; Stanley Heptinstall; Robert G Wilcox; Gary Peters; Mark Wickens; Håkan Emanuelsson; Paul Gurbel; Peer Grande; Christopher P Cannon
Journal:  J Am Coll Cardiol       Date:  2007-10-23       Impact factor: 24.094

5.  Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.

Authors:  Laurent Bonello; Marc Laine; Nathalie Kipson; Julien Mancini; Olfa Helal; Julien Fromonot; Vlad Gariboldi; Jocelyne Condo; Franck Thuny; Corinne Frere; Laurence Camoin-Jau; Franck Paganelli; Françoise Dignat-George; Regis Guieu
Journal:  J Am Coll Cardiol       Date:  2013-11-27       Impact factor: 24.094

6.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

Review 7.  Sick sinus syndrome: a review.

Authors:  Michael Semelka; Jerome Gera; Saif Usman
Journal:  Am Fam Physician       Date:  2013-05-15       Impact factor: 3.292

8.  Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease.

Authors:  M Brodsky; D Wu; P Denes; C Kanakis; K M Rosen
Journal:  Am J Cardiol       Date:  1977-03       Impact factor: 2.778

9.  Ticagrelor and bradycardia: a nested case-control study.

Authors:  Ricky D Turgeon; Kimberly A Fernandes; David Juurlink; Jack V Tu; Muhammad Mamdani
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-10-07       Impact factor: 2.890

Review 10.  Anti-platelet therapy: ADP receptor antagonists.

Authors:  Yanushi Dullewe Wijeyeratne; Stan Heptinstall
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.